Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On March 8, 2023, Jami Rubin notified EQRx, Inc. (EQRx) of her decision to step
down as Chief Financial Officer (and as principal financial officer and
principal accounting officer) of EQRx effective March 31, 2023. Ms. Rubin's
departure is not related to a disagreement with EQRx on any matter relating to
EQRx's operations, policies or practices. EQRx thanks Jami for her service and
contributions to EQRx and wishes her all the best as she contemplates new
endeavors.
Accordingly, on March 9, 2023, EQRx's board of directors (the Board) appointed
Melanie Nallicheri, EQRx's President and Chief Executive Officer and principal
executive officer, as principal financial officer, with immediate effect, and
plans to conduct a search for a successor chief financial officer.
Ms. Nallicheri, age 54, has been EQRx's President, Chief Executive Officer and
member of the Board since December 2021 and is a co-founder of EQRx
International, Inc. and was the President and Chief Operating Officer of EQRx
International, Inc. since August 2019 and effective September 1, 2021 assumed
the role of President and Chief Executive Officer and joined EQRx
International, Inc.'s board of directors. Ms. Nallicheri is a healthcare and
life sciences executive with nearly three decades of experience. Prior to
joining EQRx International, Inc., from September 2016 to April 2019,
Ms. Nallicheri served as Chief Business Officer and Head of Biopharma for
Foundation Medicine, Inc. Prior to that, from 2013 to June 2016, Ms. Nallicheri
served in a variety of roles at McKesson Corporation, including as Senior Vice
President, Corporate Strategy and Business Development at McKesson Distribution
Solutions and McKesson Data & Analytics; and prior thereto, from 2011 to 2013 as
Senior Vice President, Corporate Development at Geron Corporation.
Ms. Nallicheri holds an M.S. in business and economics from WHU Otto Beisheim
School of Corporate Management in Koblenz, Germany and an M.B.A. with honors
from Columbia Business School.
There are no understandings or arrangements between Ms. Nallicheri and any other
person pursuant to which she was appointed as principal financial officer, and,
as previously disclosed in EQRx's Annual Report on Form 10-K for the year ended
December 31, 2022, Ms. Nallicheri has no material interest in any transaction or
proposed transaction in which EQRx is or is to be a party. Ms. Nallicheri has no
family relationship with any director or executive officer of EQRx.
© Edgar Online, source Glimpses